Prof. Dr. Amos Toren, Ph.D., MHA
CAR T-cell therapy, hematology, and pediatric hemato-oncology
CAR T-cell therapy, hematology, and pediatric hemato-oncology
Overview
Country, City
Israel, Ramat Gan
Health facility
SHEBA Medical Center Ramat Gan
Medical unit
Department of CAR T-cell therapy
About the doctor
Skills & Expertise
children
leukemia
cancer
bone marrow
lymphoblastic leukemia
stem cell transplantation
lymphoma
hematology
bone marrow transplantation
myeloid
hematopoietic stem cell
neuroblastoma
blood stem
car tcell therapy
tumor
cart
hematooncology
glioblastoma
immunotherapy
chemotherapy
mutations
blood stem cell
umbilical cord blood
malignant
hematological malignancies
umbilical cord
pediatric hematooncology
bronchoscopy
anemia
thromboembolism
cart cell
growth factor
stromal cells
lymphoblastic lymphoma
fanconi anemia
resistance cancer
fechtner syndrome
ewing sarcoma
brain cancer
glioblastoma multiforme
venous thromboembolism
blood transplantation
brain tumors
pediatrics
aplastic anemia
glial tumors
ewing tumor
spinal fluid
breast cancer
embryonal cancers
Resume
CV (Curriculum Vitae)
Education
- 1977-1983 Studied human medicine at the Tel Aviv University
- Obtaining a license for medical practice
- 1985-1990 Residency at the Department of pediatrics at the SHEBA Medical Center Ramat Gan
- 1990 Obtaining specialization in pediatrics
- 1990-1992 Residency at the Department of hematology at the SHEBA Medical Center Ramat Gan
- 1992 Received additional qualifications in the field of general hematology
- 1995 Obtaining further specialization in pediatric hemato-oncology
- 1996 Visiting Professor at the Department of bone marrow transplantation at the Hadassah University Hospital
- 1998-2002 Ph.D. degree in genetics at the Tel Aviv University: “Assessing the genetic changes in the Fechtner syndrome”
- 2006-2007 Master of health administration at the Recannati Business School in Tel Aviv
Experience
- 2006-2010 Head of the Department of hematology at the Tel Aviv University
- 2002 Director of the Department of CAR T-cell therapy at the SHEBA Medical Center Ramat Gan
- Associate Professor of hematology at the Tel Aviv University
Awards & Memberships
- 1996 Member of the Ministry of Health Cord Blood committee
- 2009 Member of the Ministry of Health Palliative Care committee
- 2004-2018 Member of the subcommittee of the scientific council for authorization of the Department of pediatric and hematology
- 2017 Member of the Israeli Ministry of Health "Pharmaceutical Basket" committee
- Member of the Israeli Pediatric Society
- Member of the Israeli Society of Hematology
- Member of the Israeli Society of Pediatric Hematology-Oncology
- Member of the European Society of Pediatric Hematology
- Member of the European group for blood and marrow transplantation
- Member of the American Society of Hematology
- Member of the children's oncology group
- Member of the Center for International Blood and Marrow Transplant Research
Languages
English
Hebrew
Publications
Cerebral Spinal Fluid Parameters Following CD19-Targeted Therapies in Children and Young Adults.
9 October, 2023
Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose.
25 September, 2023
Examining Bias in Published Surgical Glaucoma Clinical Trials.
20 July, 2023
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. Amos Toren, Ph.D., MHA?
The primary specialization of the doctor is CAR T-cell therapy, hematology, and pediatric hemato-oncology.
What is the experience of the specialist?
Prof. Dr. Amos Toren, Ph.D., MHA has been practicing for more than 41 years.
Prof. Dr. Amos Toren, Ph.D., MHA
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. Amos Toren, Ph.D., MHA